Have you heard of the MaRISS, PROSPER, and ARAMIS clinical research studies?
American Heart Association is pleased to the opportunity to be included in two new research studies, MaRISS and PROSPER.
- Mild and Rapidly Improving Stroke Study (MaRISS) a multi-center study trial designed to evaluate the long-term outcomes of patients with a diagnosis of mild stroke? Want more information? Contact Edna Kavuma, Program Manager at 214-706-1994 or firstname.lastname@example.org
- Patient-centered Research into Outcomes Stroke Patients prefer and Effectiveness Research (PROSPER) is a multi-center study that will evaluate post-discharge functional status, disability, depression and quality of life in stroke survivors. For more information contact Laura Drew, Coordinator, at 919-668-8892 or PROSPER@dm.duke.edu.
- ARAMIS (Addressing Real-world Anticoagulant Management Issues in Stroke) is a multi-center study that will provide important and timely insight into the management of acute stroke patients who are taking novel oral anticoagulant (NOA) prior to stroke. Want more information? Please contact DCRI at ARAMIS@dm.duke.edu.
We thank you for your continued interest in MaRISS, PROSPER and ARAMIS studies and look forward to working with you on either or both of these clinical research studies.